Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The third International Scientific Tendinopathy Symposium - New Approaches to Tendon Therapeutics - is being held in St Hilda's College, Oxford, on Friday 5 and Saturday 6 September. The event brings together an unprecedented mix of excellent basic and translational science and the finest clinical expertise.

The third International Scientific Tendinopathy Symposium - New Approaches to Tendon Therapeutics - is being held in St Hilda's College, Oxford, on Friday 5 and Saturday 6 September. The event brings together an unprecedented mix of excellent basic and translational science and the finest clinical expertise.

In addition to the scientific meeting, featuring twelve international plenary speakers, along with open papers and poster sessions, there will be two satellite events on Sunday 7 September - a hands-on clinical workshop on tendinopathy and a consensus meeting on outcome measures.

The meeting has proved highly popular and is now fully booked, but you can follow the meeting and join the discussion on Twitter using hashtag #Tendons2014.

The Symposium is co-chaired by NDORMS Head of Department Professor Andrew Carr, Associate Professor Philippa Hulley, also of NDORMS and Associate Professor Mark Thompson, of the Institute of Biomedical Engineering, Oxford.

Speaking of the event, Prof Thompson says: "ISTS 2014 will pull together exciting plenary speakers, excellent scientists and expert clinicians in the inspiring surroundings of St Hilda's College to find new ways of treating painful and debilitating tendon disease. The meeting venue is full, but social media will take the conversations wider and further, and we will be posting video of the final discussion session."

The meeting proceedings will be published in the BJSM soon after the event.

For the first time in its three-edition history, the meeting is co-sponsored by the International Symposium on Ligaments and Tendons, while the commercial sponsors are the British Journal of Sports Medicine (BJSM), UTC Imaging BV, TRB Chemedica, Biomet, Mathys, RegenLab and Bose.

Prof Thompson has already spoken to BJSM about this year's Symposium and a podcast is online. This year's programme is also published.

Similar stories

New centre aims to help companies conduct more efficient trials

Botnar Main Trials

A new clinical therapeutics centre has been set up by the University of Oxford to help life sciences companies identify interventions that have the greatest potential to deliver patient benefit, and so bring down the cost of early phase clinical trials.

Cognitive–behavioural therapy consistently improves quality of life

Main Rehabilitation and self-management Research

A meta-review of the available research into cognitive behavioural therapy reveals it consistently improves health-related quality of life across different medical conditions and demographic populations.

Oxford to collaborate with Janssen to map the cellular landscape of immune mediated disorders

Main Research

The University of Oxford has entered into a strategic collaboration with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson.

Versus Arthritis Foundation Fellowship awarded to Dr Kristina Zec

Awards Main

Dr Kristina Zec has been awarded a Versus Arthritis Foundation Fellowship to investigate the role of products of lipid oxidation produced by synovial macrophages in triggering articular inflammation.

Study reveals the safety of bisphosphonates in chronic kidney disease

Main

The results of an observational study published in JMBR and funded by the Health Technology Assessment Programme shows that bisphosphonate use is associated with a greater risk of chronic kidney disease progression.

WHiTE Four trial results published

Hip Main OCTRU Orthopaedics and trauma Research

The results of the WHiTE Four clinical trial for the treatment of fragility hip fractures have been published in The Bone and Joint Journal.